These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7669730

  • 1. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
    Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, Augenlicht L.
    Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
    [Abstract] [Full Text] [Related]

  • 2. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation.
    Augenlicht L, Shi L, Mariadason J, Laboisse C, Velcich A.
    Oncogene; 2003 Aug 07; 22(32):4983-92. PubMed ID: 12902981
    [Abstract] [Full Text] [Related]

  • 3. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW, Lotan D, Lotan R.
    Cancer Res; 1994 Nov 15; 54(22):5992-6000. PubMed ID: 7954433
    [Abstract] [Full Text] [Related]

  • 4. Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells.
    Heerdt BG, Houston MA, Rediske JJ, Augenlicht LH.
    Cell Growth Differ; 1996 Jan 15; 7(1):101-06. PubMed ID: 8788038
    [Abstract] [Full Text] [Related]

  • 5. Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells.
    Mack DR, Hollingsworth MA.
    Biochem Biophys Res Commun; 1994 Mar 15; 199(2):1012-8. PubMed ID: 8135773
    [Abstract] [Full Text] [Related]

  • 6. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY, Shamsuddin AM.
    Anticancer Res; 1995 Mar 15; 15(6B):2479-87. PubMed ID: 8669811
    [Abstract] [Full Text] [Related]

  • 7. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells.
    Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C, O'Keane JC.
    J Cell Physiol; 1994 Oct 15; 161(1):111-23. PubMed ID: 7929596
    [Abstract] [Full Text] [Related]

  • 8. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
    Gope R, Gope ML.
    Cell Mol Biol (Noisy-le-grand); 1993 Sep 15; 39(6):589-97. PubMed ID: 8220069
    [Abstract] [Full Text] [Related]

  • 9. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose.
    Gaudier E, Jarry A, Blottière HM, de Coppet P, Buisine MP, Aubert JP, Laboisse C, Cherbut C, Hoebler C.
    Am J Physiol Gastrointest Liver Physiol; 2004 Dec 15; 287(6):G1168-74. PubMed ID: 15308471
    [Abstract] [Full Text] [Related]

  • 10. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
    Velcich A, Corner G, Palumbo L, Augenlicht L.
    Oncogene; 1999 Apr 22; 18(16):2599-606. PubMed ID: 10353603
    [Abstract] [Full Text] [Related]

  • 11. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
    Barnard JA, Warwick G.
    Cell Growth Differ; 1993 Jun 22; 4(6):495-501. PubMed ID: 8373733
    [Abstract] [Full Text] [Related]

  • 12. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug 22; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

  • 13. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
    Hay FG, Duncan LW, Langdon SP, Leonard RC.
    Br J Cancer Suppl; 1991 Jun 22; 14():33-5. PubMed ID: 1645568
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS.
    Cancer Res; 1993 Feb 01; 53(3):641-51. PubMed ID: 7678777
    [Abstract] [Full Text] [Related]

  • 15. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB.
    Oncogene; 2001 Oct 25; 20(48):7051-63. PubMed ID: 11704829
    [Abstract] [Full Text] [Related]

  • 16. Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.
    Han SY, Lee MS, Kim HR, Baek SH, Ahn DH, Chae HS, Erickson RH, Sleisenger MH, Kim YS.
    Int J Oncol; 2000 Sep 25; 17(3):487-94. PubMed ID: 10938388
    [Abstract] [Full Text] [Related]

  • 17. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells.
    Guilbaud NF, Gas N, Dupont MA, Valette A.
    J Cell Physiol; 1990 Oct 25; 145(1):162-72. PubMed ID: 2211839
    [Abstract] [Full Text] [Related]

  • 18. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
    Foss FM, Veillette A, Sartor O, Rosen N, Bolen JB.
    Oncogene Res; 1989 Oct 25; 5(1):13-23. PubMed ID: 2476706
    [Abstract] [Full Text] [Related]

  • 19. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
    Ho SB, Ewing SL, Montgomery CK, Kim YS.
    Oncol Res; 1996 Oct 25; 8(2):53-61. PubMed ID: 8859775
    [Abstract] [Full Text] [Related]

  • 20. Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.
    Dahiya R, Lesuffleur T, Kwak KS, Byrd JC, Barbat A, Zweibaum A, Kim YS.
    Cancer Res; 1992 Sep 01; 52(17):4655-62. PubMed ID: 1511431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.